Urgent calls for diabetes funding in 2025-26 Federal Budget 4 February 2025 The Diabetes Alliance has called on the Federal Government to commit to, and fund, the recommendations of the Parliament Inquiry into Diabetes. In a submission to the Federal Budget process, the Alliance highlighted key priorities from the recommendations including access to diabetes technologies, investment in research, support for the diabetes workforce and investment in prevention. With over two million Australians living with diagnosed and undiagnosed diabetes, the condition is the cause of a growing crisis costing the health system $3.4 billion annually. The Parliamentary Inquiry report, The State of Diabetes Mellitus in Australia, includes 23 recommendations including support for expanding access to diabetes technologies, coordinating diabetes research, better funding the diabetes workforce and investing in diabetes prevention. The recommendations are a comprehensive package of measures that would begin to stem the tide of Australia’s diabetes epidemic Diabetes Australia’s position statement on equitable access to technology formed part of the budget submission. It advocates for a staged approach to expanding subsidies for insulin pumps for people living with type 1 diabetes and continuous glucose monitoring devices for people living with type 2 diabetes. More funding for diabetes research is also a key focus for the Federal Budget. A decline in funding for diabetes research in Australia has had a significant impact on the field. In 2023, NHMRC (the Australian Government’s primary health and medical research funding agency), provided only $19 million for diabetes research, which is less than half of the amount allocated in 2022. A budget submission from the Australian Diabetes Society, Diabetes Australia and the Australian Diabetes Educators Association calls for $50 million in funding for priority areas of research including the causes of diabetes, prevention and remission, complications, and the rates of diabetes in the general population; as well as $75 million for diabetes-specific investigator grants. The sector acknowledges and celebrates the Federal Government’s announcement last year to fund the Clinical Research Network of JDRF Australia. This is a significant investment in type 1 diabetes research. The Alliance is advocating for investment in other areas of diabetes research as well. The Australian Diabetes Alliance The Australian Diabetes Alliance comprises the country’s major diabetes organisations in collective advocacy for the sector: Diabetes Australia, the Australian Diabetes Educators Association, the Australian Diabetes Society, JDRF Australia, the Australasian Diabetes in Pregnancy Society, and the Australian and New Zealand Society for Paediatric Endocrinology and Diabetes.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading